ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2013

Lenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales.

Ruth E Brown et al.PubMed ↗Publisher ↗

No numbers read from the abstract.